Complete Filing Data
Ensysce Biosciences, Inc. reported Stockholders Equity of $3.21 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Ensysce Biosciences, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$10.2M | -$8.0M | -$10.6M | -$24.2M | -$29.1M | $2.4M | $366.0K | $2.1M |
| Revenue * | $5.1M | $5.2M | $2.2M | $2.5M | $3.5M | $3.9M | ||
| Operating Income Loss | -$10.2M | -$6.7M | -$10.7M | -$24.2M | -$19.9M | -$1.6M | -$3.3M | -$959.2K |
| Operating Expenses | $15.3M | $11.9M | $12.9M | $26.7M | $23.4M | $5.5M | $3.3M | $1.6M |
| Nonoperating Income Expense | $64.8K | -$1.3M | $91.9K | $14.4K | -$9.3M | $1.5M | ||
| Other Nonoperating Income Expense | $73.4K | $17.3K | $15.4K | $86.2K | -$282.3K | |||
| Research And Development Expense | $10.4M | $7.2M | $7.6M | $19.8M | $4.7M | $4.4M | ||
| Net Income Loss Attributable To Noncontrolling Interest | -$487.00 | -$74.00 | -$13.2K | -$35.4K | -$62.2K | -$217.6K | ||
| Net Income Loss Available To Common Stockholders Basic | -$10.2M | -$8.0M | -$10.6M | -$25.1M | -$29.9M | $56.8K | ||
| Interest Expense | $353.9K | $109.5K | $1.3M | $995.5K | ||||
| General And Administrative Expense | $4.9M | $4.7M | $5.4M | $6.9M | $18.7M | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $2.6M | $921.2K | $2.7M | |||||
| Income Tax Expense Benefit | $244.5K | $555.2K | $553.9K | |||||
| Income Taxes Paid Net | $2.5K | $3.2K | $3.2K | $1.6K | $1.6K | $1.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$3.7M | -$1.7M | -$1.9M | $661.8K | -$2.0M | -$3.1M | -$2.7M | -$2.2M | -$2.2M | -$9.9M | -$7.9M | -$950.9K | -$17.2M | -$935.5K | -$1.7M | $1.6M | -$704.5K | $1.8M | $489.7K | $418.9K | $775.9K | $577.6K | $415.1K | $406.1K | -$31.2K | -$5.0K |
| Revenue * | $493.1K | $1.4M | $1.3M | $3.4M | $181.8K | $305.7K | $435.4K | $490.5K | $789.6K | $279.4K | $207.5K | $603.1K | $1.2M | $444.5K | $250.6K | $827.6K | $1.8M | |||||||||
| Operating Income Loss | -$3.7M | -$1.8M | -$2.0M | $644.7K | -$2.0M | -$1.8M | -$2.7M | -$2.3M | -$2.6M | -$6.2M | -$7.1M | -$4.8M | -$16.9M | -$412.6K | -$524.3K | -$404.8K | $139.1K | -$915.2K | -$584.4K | -$625.9K | -$189.2K | -$248.2K | -$311.5K | -$170.1K | -$146.7K | -$5.0K |
| Operating Expenses | $4.2M | $3.1M | $3.3M | $2.8M | $2.1M | $2.1M | $3.1M | $2.8M | $3.4M | $6.4M | $7.3M | $5.4M | $18.1M | $857.1K | $774.8K | $1.2M | $1.7M | $915.2K | $584.4K | $625.9K | $189.2K | $848.2K | $311.5K | $170.1K | $5.0K | |
| Nonoperating Income Expense | $12.0K | $17.0K | $21.9K | $17.0K | -$12.4K | -$1.3M | $16.5K | $54.7K | $369.4K | -$3.7M | -$867.9K | $3.9M | -$312.7K | -$545.0K | -$387.4K | $2.0M | -$845.6K | |||||||||
| Other Nonoperating Income Expense | $17.3K | $21.0K | $15.9K | $14.7K | $7.4K | -$34.5K | $6.9K | $11.0K | $5.4K | $8.7K | $2.9K | $8.0K | $61.8K | -$347.6K | -$1.5M | $2.8M | ||||||||||
| Research And Development Expense | $3.0M | $1.9M | $1.9M | $1.7M | $947.2K | $778.9K | $1.9M | $1.6M | $1.8M | $4.8M | $5.3M | $3.1M | $1.7M | $463.2K | $284.4K | $893.0K | $1.4M | |||||||||
| Net Income Loss Attributable To Noncontrolling Interest | -$166.00 | -$74.00 | -$1.2K | -$7.1K | -$3.9K | -$21.5K | -$26.3K | $182.00 | -$35.9K | -$22.1K | -$4.0K | -$20.0K | -$2.0K | |||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$3.7M | -$1.7M | -$1.9M | $661.8K | -$2.0M | -$3.1M | -$2.7M | -$2.2M | -$2.2M | -$9.9M | -$8.0M | -$1.7M | -$17.2M | -$935.5K | -$907.7K | |||||||||||
| Interest Expense | $1.2M | $7.6K | $1.5K | $4.9K | $37.8K | $15.0K | $24.7K | $910.3K | $347.8K | $216.2K | $201.7K | $31.4K | ||||||||||||||
| General And Administrative Expense | $1.3M | $1.2M | $1.4M | $1.1M | $1.2M | $1.4M | $1.2M | $1.1M | $1.6M | $1.7M | $2.0M | $2.3M | $16.4M | $393.9K | ||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.8M | -$285.4K | $3.3M | $1.9M | $504.0K | $646.1K | $990.3K | $707.8K | $544.9K | $519.2K | -$27.6K | -$5.0K | ||||||||||||||
| Income Tax Expense Benefit | -$61.3K | -$504.2K | $693.9K | $74.6K | $14.3K | $227.2K | $214.4K | $130.1K | $129.8K | $113.1K | $3.6K | |||||||||||||||
| Income Taxes Paid Net | $1.6K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $3.2M | $3.7M | -$322.9K | -$3.7M | -$7.9M | -$6.4M | -$6.7M | $5.0M | $5.0M |
| Retained Earnings Accumulated Deficit | -$139.7M | -$129.5M | -$121.6M | -$110.9M | -$85.8M | -$56.0M | $2.5M | $2.1M | -$31.2K |
| Common Stock Value | $459.00 | $136.00 | $21.00 | $53.00 | $124.00 | $1.6K | $638.00 | $604.00 | $673.00 |
| Liabilities | $4.6M | $2.2M | $3.4M | $9.9M | $24.6M | $7.0M | $10.3M | $7.4M | $7.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $4.3M | $3.5M | $1.1M | $3.1M | $12.3M | $194.2K | $341.5K | ||
| Liabilities Current | $4.6M | $2.2M | $3.3M | $9.5M | $16.5M | $7.0M | $2.8M | $437.9K | $156.2K |
| Liabilities And Stockholders Equity | $7.5M | $5.6M | $2.7M | $5.9M | $16.4M | $351.8K | $196.5M | $204.8M | $202.4M |
| Assets | $7.5M | $5.6M | $2.7M | $5.9M | $16.4M | $351.8K | $196.5M | $204.8M | $202.4M |
| Assets Current | $7.2M | $5.3M | $2.3M | $5.3M | $15.7M | $347.9K | $1.2M | $1.9M | $2.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $808.3K | $2.4M | -$2.0M | -$9.1M | $12.1M | -$147.3K | |||
| Accounts Payable Current | $3.3M | $1.4M | $1.9M | $2.9M | $301.1K | $1.7M | $429.2K | $112.0K | |
| Redeemable Noncontrolling Interest Equity Common Carrying Amount | $181.2M | $192.4M | $190.3M | ||||||
| Common Stock Subject To Possible Redemption Shares | 5.1K | 17.5M | 19.0M | ||||||
| Change In Fair Value Of Liability Classified Warrants | $10.1K | $16.3K | $284.0K | $6.7M | -$1.4M | ||||
| Cash | $4.3M | $3.5M | $1.1M | $3.1M | $12.3M | $194.2K | |||
| Other Assets Noncurrent | $85.9K | $252.6K | $419.2K | $585.9K | $754.8K | $3.8K | |||
| Other Accrued Liabilities Current | $993.4K | $548.5K | $542.3K | $2.2M | $3.4M | $344.8K | |||
| Minority Interest | -$329.0K | -$328.5K | -$328.4K | -$315.2K | -$279.8K | -$217.6K | |||
| Cash And Cash Equivalents At Carrying Value | $4.3M | $3.5M | $1.1M | $3.1M | $12.3M | $194.2K | |||
| Notes Payable Current | $306.7K | $301.7K | $854.7K | $4.3M | $12.7M | $4.2M | |||
| Provision For Loan Lease And Other Losses | -$150.00 | -$3.00 | -$1.8K | $2.0K | |||||
| Unbilled Receivables Current | $420.3K | $124.1K | $97.6K | $276.8K | $441.7K | ||||
| Interest Earned On Marketable Securities Held In Trust Account | -$4.2M | -$3.6M | |||||||
| Deferred Underwriting Fee Payable | $7.0M | $7.0M | $7.0M | ||||||
| Assets Held In Trust Noncurrent | $195.3M | $202.9M | $200.1M | ||||||
| Liabilities Noncurrent | $10.1K | $26.4K | $450.5K | $8.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.2M | $3.4M | $3.0M | $6.9M | $1.8M | $3.7M | $1.5M | $4.1M | $166.7K | -$6.1M | -$491.6K | $1.4M | -$105.7K | $5.4M | $1.9M | $5.0M | $5.0M | $4.5M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $20.0K | ||
| Retained Earnings Accumulated Deficit | -$137.0M | -$133.2M | -$131.5M | -$126.0M | -$126.6M | -$124.7M | -$118.1M | -$115.4M | -$113.1M | -$105.4M | -$95.5M | -$87.5M | -$75.0M | -$57.8M | -$2.9M | $4.9M | $4.7M | $2.1M | $3.8M | $3.3M | $2.9M | $1.4M | $790.0K | $374.9K | -$5.0K | |||
| Common Stock Value | $320.00 | $241.00 | $165.00 | $1.4K | $815.00 | $733.00 | $287.00 | $267.00 | $128.00 | $221.00 | $3.6K | $3.0K | $2.4K | $2.4K | $622.00 | $624.00 | $626.00 | $660.00 | $614.00 | $610.00 | $605.00 | $603.00 | $601.00 | $599.00 | $719.00 | |||
| Liabilities | $2.3M | $2.5M | $1.9M | $2.8M | $1.3M | $1.7M | $2.1M | $2.6M | $4.1M | $14.7M | $8.7M | $11.3M | $10.1M | $4.0M | $11.1M | $8.0M | $8.4M | $52.1M | $8.1M | $7.8M | $7.4M | $7.4M | $7.1M | $7.2M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $1.7M | $2.2M | $3.1M | $4.2M | $1.0M | $3.4M | $1.5M | $3.8M | $1.4M | $4.5M | $3.7M | $8.4M | $6.8M | $8.0M | $289.9K | $724.4K | $581.0K | $168.0K | ||||||||||
| Liabilities Current | $2.3M | $2.5M | $1.8M | $2.8M | $1.3M | $1.6M | $2.0M | $2.5M | $4.0M | $11.9M | $8.2M | $8.8M | $7.0M | $4.0M | $319.2K | $452.1K | $793.6K | $3.5M | $1.1M | $327.4K | $387.2K | $359.2K | $135.2K | $197.4K | $380.0K | |||
| Liabilities And Stockholders Equity | $3.2M | $5.6M | $4.6M | $9.4M | $2.8M | $5.1M | $3.2M | $6.4M | $3.9M | $8.3M | $7.9M | $12.4M | $9.7M | $9.2M | $13.0M | $13.3M | $13.4M | $61.6M | $207.2M | $206.4M | $205.6M | $204.0M | $203.2M | $202.9M | $400.0K | |||
| Assets | $3.2M | $5.6M | $4.6M | $9.4M | $2.8M | $5.1M | $3.2M | $6.4M | $3.9M | $8.3M | $7.9M | $12.4M | $9.7M | $9.2M | $13.0M | $13.3M | $13.4M | $61.6M | $207.2M | $206.4M | $205.6M | $204.0M | $203.2M | $202.9M | $400.0K | |||
| Assets Current | $2.9M | $5.3M | $4.4M | $9.1M | $2.5M | $4.7M | $2.8M | $5.9M | $3.4M | $7.7M | $7.2M | $11.7M | $8.9M | $8.4M | $228.2K | $101.8K | $186.3K | $274.3K | $1.4M | $1.5M | $1.6M | $1.9M | $1.9M | $2.1M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$449.6K | $2.3M | -$1.7M | -$3.8M | $95.7K | -$893.2K | ||||||||||||||||||||||
| Accounts Payable Current | $463.5K | $1.0M | $615.3K | $2.0M | $482.0K | $981.7K | $916.4K | $1.3M | $1.6M | $1.3M | $3.0M | $959.6K | $471.9K | $3.1M | $326.4K | $163.7K | $3.5M | $2.8M | $1.1M | $745.6K | $341.6K | $350.2K | $126.6K | $72.0K | ||||
| Redeemable Noncontrolling Interest Equity Common Carrying Amount | $194.1M | $193.6M | $193.2M | $191.7M | $191.1M | $190.7M | ||||||||||||||||||||||
| Common Stock Subject To Possible Redemption Shares | 26.2K | 5.2K | 433.8K | |||||||||||||||||||||||||
| Change In Fair Value Of Liability Classified Warrants | $998.00 | -$853.00 | $9.9K | $6.4K | $7.8K | $9.0K | $17.2K | $43.6K | $219.0K | $2.7M | $148.4K | $2.8M | $405.1K | |||||||||||||||
| Cash | $1.7M | $2.2M | $3.1M | $4.2M | $1.0M | $3.4M | $1.5M | $3.8M | $1.4M | $4.5M | $3.7M | $8.4M | $6.8M | $8.0M | ||||||||||||||
| Other Assets Noncurrent | $127.6K | $292.9K | $210.9K | $294.2K | $335.9K | $377.6K | $460.9K | $502.6K | $544.2K | $627.6K | $671.4K | $713.1K | $796.4K | $838.1K | ||||||||||||||
| Other Accrued Liabilities Current | $1.5M | $1.0M | $888.5K | $447.0K | $370.2K | $408.4K | $760.5K | $785.8K | $2.4M | $2.2M | $2.7M | $1.8M | $3.7M | $411.9K | ||||||||||||||
| Minority Interest | -$328.6K | -$328.6K | -$328.5K | -$328.5K | -$328.5K | -$328.5K | -$327.4K | -$326.2K | -$319.1K | -$327.4K | -$305.9K | -$279.6K | -$279.6K | -$243.7K | ||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $1.7M | $2.2M | $3.1M | $4.2M | $1.0M | $3.4M | $1.5M | $3.8M | $1.4M | $4.5M | $3.7M | $8.4M | $6.8M | $8.0M | ||||||||||||||
| Notes Payable Current | $387.7K | $424.5K | $257.4K | $387.2K | $454.5K | $246.0K | $350.9K | $445.7K | $7.6M | $2.5M | $6.1M | $2.8M | ||||||||||||||||
| Provision For Loan Lease And Other Losses | -$46.00 | -$46.00 | -$589.00 | |||||||||||||||||||||||||
| Unbilled Receivables Current | $4.4K | $1.2M | $22.0K | $1.8M | $224.2K | $96.2K | $107.7K | $107.6K | $289.3K | $140.8K | $276.6K | $808.6K | $86.9K | $75.4K | ||||||||||||||
| Interest Earned On Marketable Securities Held In Trust Account | -$229.00 | -$640.0K | -$1.2M | -$691.2K | -$157.4K | |||||||||||||||||||||||
| Deferred Underwriting Fee Payable | $2.0M | $6.8M | $7.0M | $7.0M | $7.0M | $7.0M | $7.0M | $7.0M | $7.0M | $7.0M | $7.0M | |||||||||||||||||
| Assets Held In Trust Noncurrent | $12.7M | $12.6M | $13.2M | $13.2M | $61.3M | $205.8M | $204.9M | $203.9M | $202.1M | $201.3M | $200.7M | |||||||||||||||||
| Liabilities Noncurrent | $35.00 | $1.0K | $130.2K | $3.2K | $9.6K | $17.4K | $30.5K | $47.7K | $91.3K | $2.8M | $2.5M | $3.1M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$7.8M | -$7.5M | -$10.8M | -$17.9M | -$8.2M | -$1.2M | -$1.4M | -$1.2M |
| Net Cash Provided By Used In Financing Activities | $8.7M | $9.9M | $8.8M | $8.8M | $20.3M | $1.1M | -$11.0M | -$32.0K |
| Net Cash Provided By Used In Investing Activities | -$123.6K | $4.5K | $183.4M | $11.9M | $838.6K | |||
| Share Based Compensation | $177.1K | $110.7K | $879.2K | $1.1M | $121.8K | $178.7K | ||
| Increase Decrease In Prepaid Expenses Other | $438.6K | $252.0K | -$1.4M | -$1.7M | $1.6M | $25.4K | ||
| Increase Decrease In Other Accrued Liabilities | $434.4K | $6.2K | -$1.3M | $1.0M | $2.2M | -$1.1M | ||
| Increase Decrease In Accounts Payable | $1.8M | -$578.9K | -$1.2M | $2.6M | -$1.4M | $1.2M | ||
| Increase Decrease In Unbilled Receivable | $296.2K | $26.6K | -$179.3K | -$164.9K | $441.7K | -$173.6K | ||
| Increase Decrease In Interest Payable Net | $12.4K | $43.9K | $18.6K | $60.5K | $349.3K | |||
| Increase Decrease In Prepaid Expense | $157.5K | -$87.1K | -$130.0K | |||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $787.6K | $2.3M | $317.3K | |||||
| Proceeds From Convertible Debt | $1.6M | $7.5M | $14.0M | $1.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q3 2022 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q4 2017 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.7M | -$3.4M | -$3.6M | -$3.4M | -$517.1K | -$234.4K | -$294.4K | -$216.8K | -$251.8K | -$5.0K | |
| Net Cash Provided By Used In Financing Activities | $1.3M | $5.7M | $1.9M | -$391.3K | $612.9K | -$135.3M | -$8.6K | -$32.0K | $202.3M | $345.0K | |
| Net Cash Provided By Used In Investing Activities | $4.5K | -$62.5K | $134.6M | $151.2K | $61.4K | -$200.0M | |||||
| Share Based Compensation | $16.3K | $33.2K | $117.1K | $402.4K | $43.8K | ||||||
| Increase Decrease In Prepaid Expenses Other | -$433.7K | $86.7K | -$242.6K | -$581.8K | -$51.2K | ||||||
| Increase Decrease In Other Accrued Liabilities | $388.8K | -$133.8K | -$52.7K | $86.5K | $4.8K | ||||||
| Increase Decrease In Accounts Payable | -$741.8K | -$1.3M | -$1.3M | $658.5K | -$92.2K | ||||||
| Increase Decrease In Unbilled Receivable | -$102.1K | -$1.3K | $12.5K | $366.9K | |||||||
| Increase Decrease In Interest Payable Net | $2.9K | $27.3K | $1.5K | $15.0K | $173.4K | ||||||
| Increase Decrease In Prepaid Expense | $32.9K | $42.4K | -$17.5K | $6.8K | $217.1K | ||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $58.8K | $723.2K | -$87.7K | -$39.9K | $112.0K | ||||||
| Proceeds From Convertible Debt | $8.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.98 | -$11.45 | -$70.40 | -$139.42 | -$1.48 | $0.00 | -$0.47 | -$0.22 | |
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 150.0M | 150.0M | 100.0M | 100.0M | 100.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Authorized | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.0M | 1.0M | 1.0M |
| Common Stock Shares Outstanding | 4.6M | 1.4M | 209.7K | 534.5K | 1.2M | 15.8M | 6.4M | 6.0M | 6.7M |
| Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation | |||||||||
| Earnings Per Share Basic And Diluted Subject To Possible Redemption | |||||||||
| Preferred Stock Shares Outstanding | 3.3K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Shares Issued | 4.6M | 1.4M | 209.7K | 534.6K | 1.2M | 15.8M | 6.4M | 6.0M | 6.7M |
| Weighted Average Number Of Shares Outstanding Basic | 2.6M | 697.7K | 150.9K | 179.9K | 1.0M | 15.8M | |||
| Earnings Per Share Basic | $-3.98 | $-11.45 | $-70.40 | $-139.42 | $-29.64 | $0.00 | |||
| Preferred Stock Shares Issued | 4.0K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 6.4M | 6.1M | 6.0M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 2.6M | 697.7K | 150.9K | 179.9K | 20.2M | 16.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.29 | -$0.79 | -$1.39 | $1.00 | -$3.35 | -$8.21 | -$0.87 | -$0.98 | -$2.08 | -$61.58 | -$56.49 | -$0.71 | -$0.06 | -$0.27 | $0.09 | -$0.04 | $0.28 | -$0.08 | -$0.09 | -$0.04 | -$0.05 | -$0.05 | -$0.02 | -$0.01 | $0.00 | |
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 150.0M | 150.0M | 150.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.5M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | ||
| Common Stock Shares Outstanding | 3.2M | 2.4M | 1.6M | 13.9M | 8.2M | 7.3M | 2.9M | 2.7M | 1.3M | 2.2M | 35.5M | 29.9M | 24.3M | 6.2M | 6.3M | 6.3M | 6.6M | 6.1M | 6.1M | 6.0M | 6.0M | 6.0M | 6.0M | 7.2M | ||
| Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation | 15.9M | |||||||||||||||||||||||||
| Earnings Per Share Basic And Diluted Subject To Possible Redemption | $0.00 | |||||||||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Common Stock Shares Issued | 3.2M | 2.4M | 1.6M | 13.9M | 8.2M | 7.3M | 2.9M | 2.7M | 1.3M | 2.2M | 35.6M | 30.0M | 24.3M | 24.3M | 6.2M | 6.3M | 6.3M | 6.6M | 6.1M | 6.1M | 6.0M | 6.0M | 6.0M | 6.0M | 7.2M | |
| Weighted Average Number Of Shares Outstanding Basic | 2.9M | 2.2M | 1.4M | 659.4K | 587.8K | 379.6K | 3.1M | 2.3M | 1.1M | 160.7K | 141.6K | 113.7K | 1.2M | 16.1M | 15.8M | 15.8M | ||||||||||
| Earnings Per Share Basic | $-1.29 | $-0.79 | $-1.39 | $1.00 | $-3.35 | $-8.21 | $-0.87 | $-0.98 | $-2.08 | $-61.58 | $-56.49 | $-14.66 | $-14.15 | $-0.06 | $-0.06 | $0.10 | ||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 16.1M | 6.2M | 6.3M | 15.8M | 6.4M | 6.1M | 6.0M | 6.0M | 6.0M | 6.0M | 6.0M | 6.2M | 6.3M | |||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 2.9M | 2.2M | 1.4M | 659.4K | 587.8K | 379.6K | 3.1M | 2.3M | 1.1M | 160.7K | 141.6K | 24.3M | 16.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $177.1K | $110.7K | $879.2K | $2.8M | $121.8K | $178.7K | |||
| Fair Value Adjustment Of Warrants | $11.6M | ||||||||
| Prepaid Expense Current | $2.9M | $87.1K | $217.1K | ||||||
| Additional Paid In Capital | $142.9M | $133.3M | $121.2M | $107.2M | $78.0M | $49.5M | |||
| Investment Income Interest | $719.6K | $4.2M | $3.6M | ||||||
| Repayment Insurance Premiums | $216.3K | $372.5K | $451.7K | $595.5K | $488.5K | ||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $1.2M | $3.1M | $21.5M | $5.7M | $1.0M | ||||
| Change In Fair Value Of Convertible Notes | -$5.8M | $3.0M | |||||||
| Deemed Dividend Related To Warrants Down Round Provision | $290.00 | $12.9K | $913.2K | $803.1K | |||||
| Financed Insurance Premiums | $188.0K | $232.2K | $445.7K | $399.9K | $867.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $45.9K | $90.6K | $16.3K | $20.8K | $26.5K | $33.2K | $55.7K | $77.4K | $117.1K | $157.1K | $295.6K | $2.1M | $24.8K | $36.4K | $43.8K | $51.5K | $36.1K | ||||||||||
| Fair Value Adjustment Of Warrants | $1.5M | -$2.2M | |||||||||||||||||||||||||
| Prepaid Expense Current | $1.2M | $1.9M | $1.6M | $1.8M | $3.0M | $3.2M | $190.4K | $157.5K | $48.3K | $62.5K | $42.4K | $30.5K | $67.1K | $104.6K | $128.8K | $172.5K | $223.9K | ||||||||||
| Additional Paid In Capital | $138.2M | $136.6M | $134.5M | $132.9M | $128.4M | $128.4M | $119.5M | $119.5M | $113.3M | $99.3M | $95.0M | $88.9M | $74.9M | $63.3M | $4.8M | ||||||||||||
| Investment Income Interest | $229.00 | $1.8K | $77.6K | $640.0K | $1.1M | $1.2M | $1.2M | $969.4K | $855.1K | $691.2K | $157.4K | ||||||||||||||||
| Repayment Insurance Premiums | $47.2K | $153.7K | $204.7K | $391.3K | |||||||||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $1.2M | $3.1M | $4.1M | $5.7M | $8.1M | $5.7M | |||||||||||||||||||||
| Change In Fair Value Of Convertible Notes | -$146.5K | -$3.5M | $88.8K | -$2.8M | -$1.1M | ||||||||||||||||||||||
| Deemed Dividend Related To Warrants Down Round Provision | $290.00 | $8.3K | $715.6K | ||||||||||||||||||||||||
| Financed Insurance Premiums |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.